CoChat

Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?

Open access

Published version of a preprint

The DOI matches its Crossref record; 127 of the 128 references it cites were found in a registry or an index.

Abstract

The cancer-immune dialogue subject to immuno-oncological intervention is profoundly influenced by microenvironmental factors. Indeed, the mucosal microbiota-and more specifically, the intestinal ecosystem-influences the tone of anticancer immune responses and the clinical benefit of immunotherapy. Antibiotics blunt the efficacy of immune checkpoint inhibitors (ICI), and fecal microbial transplantation may restore responsiveness of ICI-resistant melanoma. Here, we review the yin and yang of intestinal bacteria at the crossroads between the intestinal barrier, metabolism, and local or systemic immune responses during anticancer therapies. We discuss diagnostic tools to identify gut dysbiosis and the future prospects of microbiota-based therapeutic interventions. SIGNIFICANCE: Given the recent proof of concept of the potential efficacy of fecal microbial transplantation in patients with melanoma primarily resistant to PD-1 blockade, it is timely to discuss how and why antibiotics compromise the efficacy of cancer immunotherapy, describe the balance between beneficial and harmful microbial species in play during therapies, and introduce the potential for microbiota-centered interventions for the future of immuno-oncology.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/2159-8290.cd-21-0236

Cites

127 of 127 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

5 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 127 references

Research works printed but not linked: 1

  1. Wargo, 2020, Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade [preprint], Nat Portfolio

Cited by

See all 173

Metadata

Authors
Derosa, L., Routy, B., Desilets, A., Daillère, R., Terrisse, S., Kroemer, G., & Zitvogel, L.
Affiliations
  • Inserm (FR)
  • Centre Hospitalier de l’Université de Montréal (CA)
  • 5Hematology-Oncology Division, Department of Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, Quebec, Canada.
  • Institut Gustave Roussy (FR)
  • Karolinska University Hospital (SE)
Corresponding author
  • Derosa, Lisa
  • Zitvogel, Laurence
Venue
Cancer Discovery
Published
2021-08-16
Volume
11
Issue
10
Pages
2396-2412
ISSN
  • 2159-8274 (ISSN-L)
  • 2159-8290
OpenAlex
W3193318723
Cited by
170
References
128
Citations by year
2026: 19 · 2025: 41 · 2024: 29 · 2023: 50 · 2022: 27 · 2021: 4
FWCI
2.88
Type
journal article
Language
en
Open access
Locations
  • Cancer Discovery (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Fondation Philanthropia
  • Agence Nationale de la Recherche (ANR-16-RHUS-0008)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
Keywords
gut microbiota, cancer immunotherapy, immune checkpoint inhibitors, fecal microbiota transplantation, melanoma, anti-PD-1 resistance, antibiotics, gut dysbiosis, intestinal barrier, intestinal metabolism, microbiota-based therapy, tumor microenvironment
MeSH terms
Gastrointestinal Microbiome, Humans, Immunotherapy, Neoplasms, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology? https://app.cochat.ai/papers/10.1158/2159-8290.cd-21-0236
The paper
Derosa, L., Routy, B., Desilets, A., Daillère, R., Terrisse, S., Kroemer, G., & Zitvogel, L. (2021). Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology? Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-21-0236

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.